Dr. Aaron Miller: “Multiple Sclerosis Health Center”
Having multiple sclerosis (MS) today is a lot different than it was a few decades ago. Medications like interferon beta, glatiramer acetate (Copaxone), and others have literally changed the course of this disease – for the better. "Literally with the interferons, hundreds of thousands of patients around the world have taken these drugs successfully," says Aaron Miller, MD, Professor of Neurology at the Icahn School of Medicine at Mount Sinai, and Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at the Mount Sinai Health System. Learn more
Two Mount Sinai Experts Receive Honors From the National Multiple Sclerosis Society
Sep 16, 2021 View All Press Releases